Legendary comedian Joan Rivers died on September 4 at the age 81. She suffered complications from throat surgery. Joan reportedly suffered cardiac arrest during surgery in New York. From six feet under, Rivers used social media to send you an important message: go buy the iPhone 6. According to her official social media channels, she is impressed with the design of the new iPhone 6.
Did Apple sign a deal with Rivers for iPhone 6 before her death?
The sponsored scheduled post appeared Friday on her official Facebook and Instagram pages. The post written by the Fashion Police star reached well over 1.3 million viewers before being removed. Here is what the post read:
“This badass is being replaced by an iPhone 6 (not the fat one),” the post read when it went live shortly after the new Apple product hit shelves in the US on Friday.
“I got this one in 2010, and after 4 years, my only complaint is that apps are now designed for bigger screens, and the battery is getting tired. Never had a case for it, since it was most beautiful on its own. Great achievement in design. Great product.”
Websites such as TMZ.com claim that the Friday morning’s surprise post was the result of a pre-negotiated deal with Apple Inc. (NASDAQ:AAPL). Last week, CNN reported that her personal throat doctor Dr Gwen Korovin performed an unauthorized procedure and took a selfie with Rivers while the star was under general anesthetic. Korovin was allegedly overheard saying Joan Rivers “would love this.”
iPhone 6 more durable than Galaxy S5
Anyway, the iPhone 6 and iPhone 6 Plus have been selling like hot cakes across the world. Overwhelming demand prompted Apple to push deliveries to November. The new phones have received glowing reviews from critics and users alike. A recent drop test revealed that the new iPhone 6 and its big brother are more durable than Samsung’s Galaxy S5.
Besides the larger screen, the iPhone 6 brings a faster A8 processor, a wireless chip for making payments at retail stores, and health & fitness tracking capabilities.
Apple shares rose 0.63% to $101.60 in pre-market trading Monday.